Myocardial stunning in hemodialysis: What is the overall message?

Hemodialysis International

Volumn 14, Issue 4, 2010, Pages 447-450

  Dorairajan, Smrita ^a,b   Chockalingam, Anand ^a,c   Misra, Madhukar ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Division of Nephrology   (United States)

^c University of Missouri   (United States)

Author keywords

Hemodialysis; Hypotension; Intradialytic; Myocardium; Stunning

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; VERAPAMIL;

ACUTE DISEASE; ARTICLE; BRONCHOSPASM; CARDIOVASCULAR RISK; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HEART DISEASE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; HYPOTENSION; PREVALENCE; STUNNED HEART MUSCLE;

ALGORITHMS; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL STUNNING; RENAL DIALYSIS; RISK FACTORS;

EID: 77958519149     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2010.00495.x     Document Type: Article

References (20)

1. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996; 11:1277-1285.
2. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998; 9 (Suppl):S16-S23.
3. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63:793-808.
4. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int. 1999; 55:1553-1559.
5. Dasselaar JJ, Slart RH, Knip M, et al. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant. 2009; 24:604-610.
6. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009; 4:1925-1931.
7. Chockalingam A, Mehra A, Dorairajan S, Dellsperger KC. Acute left ventricular dysfunction in the critically ill. Chest. 2010; 138:198-207.
8. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: Determinants and associated outcomes. Clin J Am Soc Nephrol. 2009; 4:914-920.
9. Hothi DK, Rees L, Marek J, Burton J, McIntyre CW. Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin J Am Soc Nephrol. 2009; 4:790-797.
10. McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease-a new aspect of cardiovascular disease. Blood Purif. 2010; 29:105-110.
11. Choy JB, Armstrong PW, Ulan RA, et al. Do cardiac troponins provide prognostic insight in hemodialysis patients? Can J Cardiol. 2003; 19:907-911.
12. Iliou MC, Fumeron C, Benoit MO, et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis. 2003; 42:513-523.
13. Chockalingam A, Xie GY, Dellsperger KC. Echocardiography in stress cardiomyopathy and acute LVOT obstruction. Int J Cardiovasc Imaging. 2010; 26:527-535.
14. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001; 38:938-942.
15. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47:186-192.
16. Selby NM, McIntyre CW. Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int. 2010.
17. Chockalingam A, Tejwani L, Aggarwal K, Dellsperger KC. Dynamic left ventricular outflow tract obstruction in acute myocardial infarction with shock: Cause, effect, and coincidence. Circulation. 2007; 116:e110-e113.
18. Chockalingam A, Dorairajan S, Bhalla M, Dellsperger KC. Unexplained hypotension: The spectrum of dynamic left ventricular outflow tract obstruction in critical care settings. Crit Care Med. 2009; 37:729-734.
19. Aronson D, Burger AJ. Concomitant beta-blocker therapy is associated with a lower occurrence of ventricular arrhythmias in patients with decompensated heart failure. J Card Fail. 2002; 8:79-85.
20. Aronson D, Burger AJ. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann Noninvasive Electrocardiol. 2001; 6:98-106.